QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, April 13, 2005, 25(15):3752-3762; doi:10.1523/JNEUROSCI.0188-05.2005

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (22) Citing Articles via Google Scholar Google Scholar Articles by Robert, A. Articles by Howe, J. R. Search for Related Content PubMed PubMed Citation Articles by Robert, A. Articles by Howe, J. R.

 Previous Article  |  Next Article 

Cellular/Molecular
AMPA Receptor Binding Cleft Mutations That Alter Affinity, Efficacy, and Recovery from Desensitization

Antoine Robert,¹ Neali Armstrong,² J. Eric Gouaux,² and James R. Howe¹

¹Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06520, and ²Department of Biochemistry and Molecular Biophysics, Columbia University, New York, New York 10032

Glutamate binds to AMPA receptors within a deep cleft between two globular protein domains (domains 1 and 2). Once glutamate binds, the cleft closes, and agonist-bound structures of the isolated ligand binding core suggest that closure of the binding cleft is sufficiently complete that it essentially prevents ligand dissociation. There is also considerable evidence supporting the view that cleft closure is the initial conformational change that triggers receptor activation and desensitization, and it has been clearly demonstrated that there is a correlation between the degree of cleft closure and agonist efficacy. It is unknown, however, whether the stability of binding cleft closure also influences receptor-channel properties. The crystallographic structures indicate that closed-cleft conformations are stabilized by the formation of hydrogen bonds that involve amino acid side chains of residues in domains 1 and 2. We show here that mutations that disrupt one such cross-cleft hydrogen bond (in the AMPA receptor subunit GluR2) decrease both agonist affinity and efficacy. The same mutations also hasten recovery from desensitization. We conclude that the stability of binding cleft closure has a significant impact on AMPA receptor function and is a major determinant of the apparent affinity of agonists. The results suggest that the stability of cleft closure has been tuned so that glutamate dissociates as rapidly as possible yet remains a full agonist.

Key words: glutamate; AMPA receptor; desensitization; binding cleft; affinity; mutations

---

Received Feb 4, 2004; revised February 18, 2005; accepted February 21, 2005.

This article has been cited by other articles:

				A.-M. L. Fay, C. R. Corbeil, P. Brown, N. Moitessier, and D. Bowie Functional Characterization and In Silico Docking of Full and Partial GluK2 Kainate Receptor Agonists Mol. Pharmacol., May 1, 2009; 75(5): 1096 - 1107. [Abstract] [Full Text] [PDF]

				Y. Zhang, N. Nayeem, and T. Green Mutations to the Kainate Receptor Subunit GluR6 Binding Pocket That Selectively Affect Domoate Binding Mol. Pharmacol., October 1, 2008; 74(4): 1163 - 1169. [Abstract] [Full Text] [PDF]

				M. L. Blanke and A. M. J. VanDongen Constitutive Activation of the N-Methyl-D-aspartate Receptor via Cleft-spanning Disulfide Bonds J. Biol. Chem., August 1, 2008; 283(31): 21519 - 21529. [Abstract] [Full Text] [PDF]

				M. L. Blanke and A. M. J. VanDongen The NR1 M3 Domain Mediates Allosteric Coupling in the N-Methyl-D-aspartate Receptor Mol. Pharmacol., August 1, 2008; 74(2): 454 - 465. [Abstract] [Full Text] [PDF]

				W. Zhang, Y. Cho, E. Lolis, and J. R. Howe Structural and Single-Channel Results Indicate That the Rates of Ligand Binding Domain Closing and Opening Directly Impact AMPA Receptor Gating J. Neurosci., January 23, 2008; 28(4): 932 - 943. [Abstract] [Full Text] [PDF]

				P. E. Chen, M. T. Geballe, E. Katz, K. Erreger, M. R. Livesey, K. K. O'Toole, P. Le, C. J. Lee, J. P. Snyder, S. F. Traynelis, et al. Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes J. Physiol., January 1, 2008; 586(1): 227 - 245. [Abstract] [Full Text] [PDF]

				K. Erreger, M. T. Geballe, A. Kristensen, P. E. Chen, K. B. Hansen, C. J. Lee, H. Yuan, P. Le, P. N. Lyuboslavsky, N. Micale, et al. Subunit-Specific Agonist Activity at NR2A-, NR2B-, NR2C-, and NR2D-Containing N-Methyl-D-aspartate Glutamate Receptors Mol. Pharmacol., October 1, 2007; 72(4): 907 - 920. [Abstract] [Full Text] [PDF]

				A. H. Ahmed, A. P. Loh, D. E. Jane, and R. E. Oswald Dynamics of the S1S2 Glutamate Binding Domain of GluR2 Measured Using 19F NMR Spectroscopy J. Biol. Chem., April 27, 2007; 282(17): 12773 - 12784. [Abstract] [Full Text] [PDF]

				W. Maier, R. Schemm, C. Grewer, and B. Laube Disruption of Interdomain Interactions in the Glutamate Binding Pocket Affects Differentially Agonist Affinity and Efficacy of N-methyl-D-aspartate Receptor Activation J. Biol. Chem., January 19, 2007; 282(3): 1863 - 1872. [Abstract] [Full Text] [PDF]

				M. C. Weston, C. Gertler, M. L. Mayer, and C. Rosenmund Interdomain Interactions in AMPA and Kainate Receptors Regulate Affinity for Glutamate J. Neurosci., July 19, 2006; 26(29): 7650 - 7658. [Abstract] [Full Text] [PDF]

				R. Jin, S. Clark, A. M. Weeks, J. T. Dudman, E. Gouaux, and K. M. Partin Mechanism of Positive Allosteric Modulators Acting on AMPA Receptors J. Neurosci., September 28, 2005; 25(39): 9027 - 9036. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help